Results - Announcements
Natco Pharma Ltd share price ticked higher by 0.43% to Rs 812.25 after the company's net profit saw a strong growth of 41.90% to Rs 173.4 crore, while revenue from operations increased sharply by 31.57% to Rs 967.3 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, rising 6.82%. It has marginally improved by 2.52% over last one week and moved up slightly by 5.98% in last one month while the market capitalization of Natco Pharma Ltd has improved by 0.63% and 1.42% in the same period respectively.
Profit before tax (PBT) of Natco Pharma Ltd stood at Rs 243.2 crore in Q2 FY27, crashing by 60.37% year-on-year, and jumping 31.03% quarter-on-quarter. EBITDA came in at Rs 206 crore, tanking 57.05% YoY and surging by 61.67% sequentially.
Total expenses surged 27.32% to Rs 758.6 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 171.7 crore, growing marginally by 8.81% YoY, while employee benefits expense was at Rs 203.6 crore, surging 13.55% YoY.
For FY26, revenue from operations declined slightly by 7.93% to Rs 4078.3 crore, while net profit tanked by 27.16% to Rs 1371.9 crore, compared to previous FY. EBITDA soared by 181190% to Rs 1138.9 crore, and PBT collapsed by 34.94% to Rs 1490.8 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 1768.3 crore in FY26, as against Rs 1696.8 crore in FY25.
Natco Pharma Ltd slipped 0.87% in last one year, outperforming the benchmark BSE Sensex which has softened by 3.42% during the same period.